Zazove Associates »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Zazove Associates

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Zazove Associates from 13F filings

Historical chart of Zazove Associates investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Zazove Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Zazove Associates

Quarter filed Position value Share count Share price at filing
2025-06-30 $5.6M 6.0M 0.93
2025-03-31 $5.6M 6.0M 0.93
2024-12-31 $6.6M 6.0M 1.10

More positions owned by Zazove Associates

Parsons Corp Del Note 2.625% 3/0 (Principal)
Ventas Rlty Ltd Partnership Note 3.750% 6/0 (Principal)
Tetra Tech DBCV 2.250% 8/1 (Principal)
Tyler Tex Indpt Sch Dist Note 0.250% 3/1 (Principal)
MKS Note 1.250% 6/0 (Principal)
Duke Energy Corp Note 4.125% 4/1 (Principal)
Fluor Corp Note 1.125% 8/1 (Principal)
Itron Note 1.375% 7/1 (Principal)
Varonis Sys Note 1.000% 9/1 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Ppl Cap Fdg Note 2.875% 3/1 (Principal)
Southern Note 4.500% 6/1 (Principal)
Global Pmts Note 1.500% 3/0 (Principal)
Haemonetics Corp Mass Note 2.500% 6/0 (Principal)
Jazz Investments I Note 3.125% 9/1 (Principal)

View all positions for Zazove Associates

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Tudor Investment Corporation
Balyasny Asset Management
Linden Advisors
Highbridge Capital Management
Oaktree Capital Management
D. E. Shaw & Co
DG Capital Management
Calamos Advisors
Davidson Kempner Capital Management
Agf Management
Readystate Asset Management
LMR Partners
State Street Corporation
Silver Point Capital
Man Group

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1